Form D · Other Technology
Acolyte Health Inc.
West Linn, OR · CIK 0001968882
Offering snapshot reported Jan 2, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Feb 22, 2024 | Amendment | $1,574,221 | $332,721vs Mar 9, 2023 | 21 | SEC filing |
| Mar 9, 2023 | Initial | $1,241,500 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568782
Source: Form D, filed Jan 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brad Bigelow | Director |
| Christopher Marsh | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
19010 Nixon Avenue
West Linn, OR, 97068
West Linn, OR, 97068